http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2576094-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dd98ad4ee076841fec541542f952f58 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 |
| filingDate | 2005-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_641aad445ef683dfb43a01e93211a415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b11daa0f734f0ec0aa44cc1f929ebc4 |
| publicationDate | 2006-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2576094-A1 |
| titleOfInvention | Ligand-dependant activation of nur77 and uses thereof |
| abstract | The present invention provides a method for inducing ligand-dependant Nur77 activation in a cell by contacting the cell with an effective dose of an agonist of Nur77. Also provided is a method for treating a mammal having a disease affected by modulation of Nur77 activity as well as a method for inducing apoptosis in a cell. The Nur77 agonists are preferably diindolylmethanes, and more preferably, methlylene-substituted diindolylmethanes. A representative example of the Nur77 agonists is 1,1-bis (3'-indolyl)-1-(p-substituted phenyl) methane. |
| priorityDate | 2004-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 125.